Cargando…

Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge

Celiac disease is the most important cause of intestinal villous atrophy. Seronegative intestinal villous atrophy, including those that are nonresponsive to a gluten-free diet, is a diagnostic challenge. In these cases, before establishing the diagnosis of seronegative celiac disease, alternative et...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins, Cláudio, Teixeira, Cristina, Ribeiro, Suzane, Trabulo, Daniel, Cardoso, Cláudia, Mangualde, João, Freire, Ricardo, Alves, Ana Luísa, Gamito, Élia, Cremers, Isabelle, Oliveira, Ana Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075602/
https://www.ncbi.nlm.nih.gov/pubmed/27803820
http://dx.doi.org/10.1155/2016/6392028
_version_ 1782461893644910592
author Martins, Cláudio
Teixeira, Cristina
Ribeiro, Suzane
Trabulo, Daniel
Cardoso, Cláudia
Mangualde, João
Freire, Ricardo
Alves, Ana Luísa
Gamito, Élia
Cremers, Isabelle
Oliveira, Ana Paula
author_facet Martins, Cláudio
Teixeira, Cristina
Ribeiro, Suzane
Trabulo, Daniel
Cardoso, Cláudia
Mangualde, João
Freire, Ricardo
Alves, Ana Luísa
Gamito, Élia
Cremers, Isabelle
Oliveira, Ana Paula
author_sort Martins, Cláudio
collection PubMed
description Celiac disease is the most important cause of intestinal villous atrophy. Seronegative intestinal villous atrophy, including those that are nonresponsive to a gluten-free diet, is a diagnostic challenge. In these cases, before establishing the diagnosis of seronegative celiac disease, alternative etiologies of atrophic enteropathy should be considered. Recently, a new clinical entity responsible for seronegative villous atrophy was described—olmesartan-induced sprue-like enteropathy. Herein, we report two uncommon cases of atrophic enteropathy in patients with arterial hypertension under olmesartan, who presented with severe chronic diarrhea and significant involuntary weight loss. Further investigation revealed intestinal villous atrophy and intraepithelial lymphocytosis. Celiac disease and other causes of villous atrophy were ruled out. Drug-induced enteropathy was suspected and clinical improvement and histologic recovery were verified after olmesartan withdrawal. These cases highlight the importance for clinicians to maintain a high index of suspicion for olmesartan as a precipitant of sprue-like enteropathy.
format Online
Article
Text
id pubmed-5075602
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-50756022016-11-01 Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge Martins, Cláudio Teixeira, Cristina Ribeiro, Suzane Trabulo, Daniel Cardoso, Cláudia Mangualde, João Freire, Ricardo Alves, Ana Luísa Gamito, Élia Cremers, Isabelle Oliveira, Ana Paula Case Rep Gastrointest Med Case Report Celiac disease is the most important cause of intestinal villous atrophy. Seronegative intestinal villous atrophy, including those that are nonresponsive to a gluten-free diet, is a diagnostic challenge. In these cases, before establishing the diagnosis of seronegative celiac disease, alternative etiologies of atrophic enteropathy should be considered. Recently, a new clinical entity responsible for seronegative villous atrophy was described—olmesartan-induced sprue-like enteropathy. Herein, we report two uncommon cases of atrophic enteropathy in patients with arterial hypertension under olmesartan, who presented with severe chronic diarrhea and significant involuntary weight loss. Further investigation revealed intestinal villous atrophy and intraepithelial lymphocytosis. Celiac disease and other causes of villous atrophy were ruled out. Drug-induced enteropathy was suspected and clinical improvement and histologic recovery were verified after olmesartan withdrawal. These cases highlight the importance for clinicians to maintain a high index of suspicion for olmesartan as a precipitant of sprue-like enteropathy. Hindawi Publishing Corporation 2016 2016-10-10 /pmc/articles/PMC5075602/ /pubmed/27803820 http://dx.doi.org/10.1155/2016/6392028 Text en Copyright © 2016 Cláudio Martins et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Martins, Cláudio
Teixeira, Cristina
Ribeiro, Suzane
Trabulo, Daniel
Cardoso, Cláudia
Mangualde, João
Freire, Ricardo
Alves, Ana Luísa
Gamito, Élia
Cremers, Isabelle
Oliveira, Ana Paula
Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge
title Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge
title_full Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge
title_fullStr Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge
title_full_unstemmed Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge
title_short Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge
title_sort seronegative intestinal villous atrophy: a diagnostic challenge
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075602/
https://www.ncbi.nlm.nih.gov/pubmed/27803820
http://dx.doi.org/10.1155/2016/6392028
work_keys_str_mv AT martinsclaudio seronegativeintestinalvillousatrophyadiagnosticchallenge
AT teixeiracristina seronegativeintestinalvillousatrophyadiagnosticchallenge
AT ribeirosuzane seronegativeintestinalvillousatrophyadiagnosticchallenge
AT trabulodaniel seronegativeintestinalvillousatrophyadiagnosticchallenge
AT cardosoclaudia seronegativeintestinalvillousatrophyadiagnosticchallenge
AT mangualdejoao seronegativeintestinalvillousatrophyadiagnosticchallenge
AT freirericardo seronegativeintestinalvillousatrophyadiagnosticchallenge
AT alvesanaluisa seronegativeintestinalvillousatrophyadiagnosticchallenge
AT gamitoelia seronegativeintestinalvillousatrophyadiagnosticchallenge
AT cremersisabelle seronegativeintestinalvillousatrophyadiagnosticchallenge
AT oliveiraanapaula seronegativeintestinalvillousatrophyadiagnosticchallenge